Reply: Spirometry remains the GOLD standard test for COPD diagnosis
Commentary in the European Respiratory Journal (June 2025) reaffirming spirometry as the essential diagnostic tool for COPD.
Commentary in the European Respiratory Journal (June 2025) reaffirming spirometry as the essential diagnostic tool for COPD.
Study analyzing risk factors and one-year outcomes of organizing pneumonia in COVID-19 hospitalized patients, evaluating the impact of corticosteroid treatment at different doses.
Discover how early-life genetic and environmental factors contribute to COPD and how emerging strategies aim to detect and intercept the disease early. Review from the European Respiratory Review, July 2025
Jean Wright presents at TEDxCharlotte how millions live with COPD unknowingly. It’s time to identify and help the “missing millions.”
Discover how ex vivo lung perfusion (EVLP) impacts the lung microbiome and its implications for improving donor lung viability and reducing transplant complications.
Sputum metagenomics reveals pan-European variation in microbial and resistome profiles in bronchiectasis: an EMBARC-BRIDGE study.
This study identifies a metabolic signature of COPD patients, involving fatty acids, amino acid and carbohydrate metabolites, using LC-MS plasma profiling.
Empirical life course lung function trajectories from ages 4–80 using data from eight cohort studies in Europe and Australia.
Expertos se reúnen en el Hospital Clínic para abordar el diagnóstico y tratamiento de las bronquiectasias en una jornada de formación multidisciplinar.
La Segunda Edición de RESPrimaria reunió a 350 profesionales en la UB con sesiones clínicas sobre EPOC, IA, nutrición, salud mental y ventilación no invasiva.